Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen inhibition of EAE involves effects on dendritic cell function.

Hong Yan Liu1, Abigail C Buenafe, Agata Matejuk

  • 1Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA.

Journal of Neuroscience Research
|September 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Helios expression in naïve CD4+ T cells decreases from neonates to older adults.

Clinical and experimental immunology·2026
Same author

AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With Double-Hit MYC and BCL2 or BCL6 and Triple Hit.

Pathology international·2026
Same author

Urinary prostaglandin E major urinary metabolite in neonates: Gestational age at birth-dependent dynamics and clinical implications.

Pediatrics and neonatology·2026
Same author

Growth and Neurodevelopment to 18 Months in Infant With Varying sn-2 Palmitate Levels in Formula: An Observational Study.

Pediatrics international : official journal of the Japan Pediatric Society·2026
Same author

Outcomes of early-phase ampicillin plus aminoglycosides versus ampicillin plus cefotaxime for preterm infants.

Pediatric research·2026
Same author

Clinicopathological and transcriptomic profiles of 101 patients with diffuse large B-cell lymphoma/high-grade B-cell lymphoma with double-hit MYC and BCL2 or BCL6 and triple hit.

Histopathology·2026

17beta-estradiol (E2) treatment suppresses experimental autoimmune encephalomyelitis (EAE) by reducing dendritic cell (DC) frequency and function. E2 treatment shifts T-cell responses away from pro-inflammatory Th1 cytokines, offering potential therapeutic strategies for multiple sclerosis.

Area of Science:

  • Immunology
  • Neuroscience
  • Endocrinology

Background:

  • Experimental autoimmune encephalomyelitis (EAE) is a mouse model for multiple sclerosis.
  • Estrogen has demonstrated suppressive effects on EAE induction.
  • Dendritic cells (DCs) play a crucial role in autoimmune diseases.

Purpose of the Study:

  • To investigate the effects of 17beta-estradiol (E2) on dendritic cells (DCs) in mouse models of EAE.
  • To elucidate the mechanisms by which E2 influences DC function and T-cell responses.

Main Methods:

  • Mice were treated with E2 and subjected to EAE induction.
  • Flow cytometry was used to analyze DC populations in the brain and spleen.
  • Splenic DCs were cultured and stimulated to assess antigen-presenting capacity and cytokine production.

Related Experiment Videos

  • T-cell cytokine profiles were analyzed after co-culture with E2-treated DCs.

    • Main Results:

    • E2 treatment significantly decreased the frequency of CD11b(+)/CD11c(+) DCs in the brain and CD11c(+)/CD8alpha(+) DCs in the spleen.
    • E2 suppressed the ability of mature DCs to present antigens to myelin basic protein (MBP)-specific T cells.
    • E2 treatment reduced the production of TNF-alpha, IFN-gamma, and IL-12 by mature DCs.
    • MBP-specific T cells co-cultured with E2-pretreated DCs showed a shift towards Th2 cytokines (IL-4, IL-10) and decreased Th1 cytokines (TNF-alpha, IFN-gamma).

    Conclusions:

    • 17beta-estradiol (E2) treatment modulates dendritic cell (DC) populations and function.
    • E2 exerts suppressive effects on DC-mediated antigen presentation and pro-inflammatory cytokine production.
    • E2 treatment promotes a shift in T-cell responses from Th1 to Th2, potentially contributing to EAE suppression.